Key Financial Data Of Group

Cyfuse Biomedical K.K. - Filing #7337491

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
2023-01-01 to
2023-03-31
Key financial data of group
Business results of group
Net sales
10,745,000 JPY
61,112,000 JPY
7,070,000 JPY
Ordinary profit (loss)
-223,692,000 JPY
-586,187,000 JPY
-167,047,000 JPY
Net assets
2,995,290,000 JPY
3,203,469,000 JPY
3,605,531,000 JPY
Total assets
3,903,842,000 JPY
4,214,809,000 JPY
4,594,521,000 JPY
Basic earnings (loss) per share
-28.38
-75.42
-21.56
Diluted earnings per share
Equity-to-asset ratio
0.764 xbrli:pure
0.760 xbrli:pure
0.785 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.